U.S. health regulators approved a pill from Bristol-Myers Squibb, the first to treat a genetic heart disease that is the most common cause of sudden cardiac death in people under age 35.
U.S. health regulators approved a pill from Bristol-Myers Squibb, the first to treat a genetic heart disease that is the most common cause of sudden cardiac death in people under age 35.
Source: Read More
PAID